Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukemia

doi:10.1084/jem.176.5.1303

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Aplan, P. D.
	Articles by Kirsch, I. R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Aplan, P. D.
	Articles by Kirsch, I. R.


Social Bookmarking

	What's this?

ARTICLES

Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukemia

PD Aplan, SC Raimondi and IR Kirsch
Navy Medical Branch, National Cancer Institute, Bethesda, Maryland 20889.

SCL gene disruptions are the most common chromosomal abnormality associated with the development of T cell acute lymphoblastic leukemia (ALL). Such disruptions can be the result of t(1;14) and t(1;7) translocations, as well as a cytogenetically undetectable interstitial deletion of chromosome 1. We present here a case of T cell ALL with a t(1;3)(p34;p21) translocation that also disrupts the SCL locus and leads to dysregulated SCL gene expression. This translocation, similar to previously reported SCL gene disruptions, appears to have been mediated, at least in part, by the V(D)J recombinase complex, since cryptic heptamer recognition sequences, as well as nontemplated N region nucleotide addition, are present at the breakpoints. The t(1;3) also disrupts a region on chromosome 3 characterized by alternating purine and pyrimidine residues, which can form a Z-DNA structure, reported to be prone to recombination events. A previously undescribed, evolutionarily conserved transcript unit is detected within 8 kb of the breakpoint on chromosome 3. This report extends the spectrum of recognized SCL translocations associated with T cell ALL, and underscores the contention that dysregulated SCL expression may be a causal event in T cell ALL.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Wang, G., Christensen, L. A., Vasquez, K. M. (2006). Z-DNA-forming sequences generate large-scale deletions in mammalian cells. Proc. Natl. Acad. Sci. USA 103: 2677-2682 [Abstract] [Full Text]
Begley, C. G., Green, A. R. (1999). The SCL Gene: From Case Report to Critical Hematopoietic Regulator. Blood 93: 2760-2770 [Full Text]
Thandla, S. P., Ploski, J. E., Raza-Egilmez, S. Z., Chhalliyil, P. P., Block, A. W., de Jong, P. J., Aplan, P. D. (1999). ETV6-AML1 Translocation Breakpoints Cluster Near a Purine/Pyrimidine Repeat Region in the ETV6 Gene. Blood 93: 293-299 [Abstract] [Full Text]
Krosl, G., He, G., Lefrancois, M., Charron, F., Romeo, P.-H., Jolicoeur, P., Kirsch, I. R., Nemer, M., Hoang, T. (1998). Transcription Factor SCL Is Required for c-kit Expression and c-Kit Function in Hemopoietic Cells. J. Exp. Med. 188: 439-450 [Abstract] [Full Text]
Faderl, S., Kantarjian, H. M., Talpaz, M., Estrov, Z. (1998). Clinical Significance of Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia. Blood 91: 3995-4019 [Full Text]
Rubnitz, J. E., Crist, W. M. (1997). Molecular Genetics of Childhood Cancer: Implications for Pathogenesis, Diagnosis, and Treatment. Pediatrics 100: 101-108 [Full Text]